Human medicines European public assessment report (EPAR): VidPrevtyn Beta, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 10/11/2022, Revision: 4, Status: Withdrawn (authorisation)

VidPrevtyn Beta: Periodic safety update report assessment 10 May 2023 to 9 November 2023

Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 29 July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 July 2024, 10:00 (CEST) to 29 July 2024, 12:00 (CEST)

Human medicines European public assessment report (EPAR): Upstelda, ustekinumab, Status: Withdrawn application (before opinion)

EMA supports pilot for joint African continental assessment procedures

Human medicines European public assessment report (EPAR): Pemetrexed Krka, pemetrexed, Date of authorisation: 22/05/2018, Revision: 6, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Fareston, toremifene, Date of authorisation: 14/02/1996, Revision: 26, Status: Authorised

Environmental Risk Assessment European Specialised Expert Community

Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa

HMPC: overview of assessment work - priority list